Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion type Assertion NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_head.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion description "[We conclude that NY-ESO-1 is an immunogenic antigen in neuroblastoma patients and represents a candidate target for immune-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_provenance.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion evidence source_evidence_literature NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_provenance.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion SIO_000772 14583496 NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_provenance.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion wasDerivedFrom befree-20150227 NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_provenance.
- NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_assertion wasGeneratedBy ECO_0000203 NP981112.RA9-NXEXcSlCrGuC1vR4Ptx_1HmlAfZCSPamZp1rWEGHU130_provenance.